Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cameron

Showing results (51-60 of 481) with videos related to

Pageof 49
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 30, 2009
Predictive signatures for chemotherapy sensitivity in breast cancer: are they ready for use in the clinic?Hervé Bonnefoi, Craig Underhill, Richard Iggo, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 10, 2013
Comparative actions of omega-3 fatty acids on in-vitro lipid droplet formationElizabeth Barber, Andrew J Sinclair, David Cameron-Smith
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Beyond trastuzumab and lapatinib: new options for HER2-positive breast cancer Dimitrios Zardavas, David Cameron, Ian Krop, et al.
Plos One|June 10, 2014
3T3-L1 preadipocytes exhibit heightened monocyte-chemoattractant protein-1 response to acute fatty acid exposureAimee L Dordevic, Nicky Konstantopoulos, David Cameron-Smith
Lancet (London, England)|August 10, 2024
Adjuvant radiotherapy omission in early breast cancer: the PROSPECT trialIan Kunkler, David Cameron, Mike Dixon, et al.
Lipids in Health and Disease|June 8, 2010
Suppressive actions of eicosapentaenoic acid on lipid droplet formation in 3T3-L1 adipocytesElizabeth Manickam, Andrew J Sinclair, David Cameron-Smith
Canadian Family Physician Medecin De Famille Canadien|September 18, 2007
Sweet successDuncan Innes, Andrew Farquhar, David Cameron, et al.
The Medical Journal of Australia|June 20, 2012
Are trans fats a problem in Australia?Gunveen Kaur, David Cameron-Smith, Andrew J Sinclair
Current Oncology (Toronto, Ont.)|March 24, 2022
Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton's Tyrosine Kinase Inhibitor in CanadaGraeme Ball, Christopher Lemieux, David Cameron, et al.
Journal of the American Dietetic Association|January 17, 2002
Behavior and beliefs related to dietary fat are influenced by weight-control statusAnna Timperio, David Crawford, Cate Burns, et al.
Pageof 49

Showing results (51-60 of 481) with videos related to

Sort By:
Pageof 49
European Journal of Cancer (Oxford, England : 1990)|May 30, 2009
Predictive signatures for chemotherapy sensitivity in breast cancer: are they ready for use in the clinic?Hervé Bonnefoi, Craig Underhill, Richard Iggo, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 10, 2013
Comparative actions of omega-3 fatty acids on in-vitro lipid droplet formationElizabeth Barber, Andrew J Sinclair, David Cameron-Smith
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Beyond trastuzumab and lapatinib: new options for HER2-positive breast cancer Dimitrios Zardavas, David Cameron, Ian Krop, et al.
Plos One|June 10, 2014
3T3-L1 preadipocytes exhibit heightened monocyte-chemoattractant protein-1 response to acute fatty acid exposureAimee L Dordevic, Nicky Konstantopoulos, David Cameron-Smith
Lancet (London, England)|August 10, 2024
Adjuvant radiotherapy omission in early breast cancer: the PROSPECT trialIan Kunkler, David Cameron, Mike Dixon, et al.
Lipids in Health and Disease|June 8, 2010
Suppressive actions of eicosapentaenoic acid on lipid droplet formation in 3T3-L1 adipocytesElizabeth Manickam, Andrew J Sinclair, David Cameron-Smith
Canadian Family Physician Medecin De Famille Canadien|September 18, 2007
Sweet successDuncan Innes, Andrew Farquhar, David Cameron, et al.
The Medical Journal of Australia|June 20, 2012
Are trans fats a problem in Australia?Gunveen Kaur, David Cameron-Smith, Andrew J Sinclair
Current Oncology (Toronto, Ont.)|March 24, 2022
Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton's Tyrosine Kinase Inhibitor in CanadaGraeme Ball, Christopher Lemieux, David Cameron, et al.
Journal of the American Dietetic Association|January 17, 2002
Behavior and beliefs related to dietary fat are influenced by weight-control statusAnna Timperio, David Crawford, Cate Burns, et al.
Pageof 49